SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-14.1
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex14-1.htm

Chunk 1 of 2
Word Count: 779
Character Count: 5046

Document Content:

and persons performing similar functions or any amendment (as defined below) to this Code is required to be disclosed in the Company’s Annual Report on Form 10-K or in a Current Report on Form 8-K filed with the SEC. “waiver” means the approval by the Company’s Board of Directors of a material departure from a provision of the Code. An “implicit waiver” means the Company’s failure to take action within a reasonable period of time regarding a material departure from a provision of the Code that has been made known to an executive officer of the Company. An “amendment” means any amendment to this Code other than minor technical, administrative, or other non-substantive amendments hereto. All persons should note that it is not the Company’s intention to grant or to permit waivers from the requirements of this Code. The Company expects full compliance with this Code. Other Policies and Procedures

Any
other policy or procedure set out by the Company in writing or made generally known to employees, officers, or directors of the Company
prior to the date hereof or hereafter are separate requirements and remain in full force and effect.

Inquiries

All
inquiries and questions in relation to this Code or its applicability to particular people or situations should be addressed to the Company’s
Secretary.

PROVISIONS FOR
CHIEF EXECUTIVE OFFICER AND SENIOR FINANCIAL OFFICERS

The
Chief Executive Officer and all senior financial officers, including the Chief Financial Officer and principal accounting officer, are
bound by the provisions set forth therein relating to ethical conduct, conflicts of interest, and compliance with law. In addition to
the Code, the Chief Executive Officer and senior financial officers are subject to the following additional specific policies:

Act with honesty and integrity, avoiding actual or apparent conflicts between personal, private interests and the interests of the
Company, including receiving improper personal benefits as a result of his or her position.

Disclose to the Board (and the Chief Executive Officer in the case of a senior financial officer) any material transaction or
relationship that reasonably could be expected to give rise to a conflict of interest.

Perform responsibilities with a view to causing periodic reports and documents filed with or submitted to the SEC and all other
public communications made by the Company to contain information that is accurate, complete, fair, objective, relevant, timely and
understandable, including full review of all annual and quarterly reports.

Comply with laws, rules and regulations of federal, state and local governments applicable to the Company and with the rules and
regulations of private and public regulatory agencies having jurisdiction over the Company.

Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting or omitting material facts or
allowing independent judgment to be compromised or subordinated.

Respect the confidentiality of information acquired in the course of performance of his or her responsibilities except when
authorized or otherwise legally obligated to disclose any such information; not use confidential information acquired in the course
of performing his or her responsibilities for personal advantage.

Share knowledge and maintain skills important and relevant to the needs of the Company, its stockholders and other constituencies
and the general public.

Proactively promote ethical behavior among subordinates and peers in his or her work environment and community.

Use and control all corporate assets and resources employed by or entrusted to him or her in a responsible manner.

Not use corporate information, corporate assets, corporate opportunities or his or her position with the Company for personal gain;
not compete directly or indirectly with the Company.

Comply in all respects with the Company’s Code.

Advance the Company’s legitimate interests when the opportunity arises.

The
Board will investigate any reported violations and will oversee an appropriate response, including corrective action and preventative
measures. Any officer who violates this Code will face appropriate, case specific disciplinary action, which may include demotion or
discharge.

Any
request for a waiver of any provision of this Code must be in writing and addressed to the Chairman of the Board. Any waiver of this
Code will be disclosed promptly on Form 8-K or any other means approved by the SEC.

is the policy of the Company that each officer covered by this Code shall acknowledge and certify to the foregoing annually and file
a copy of such certification with the Chairman of the Board of Directors.

OFFICER’S
CERTIFICATION

have read and understand the foregoing Code. I hereby certify that I am in compliance with the foregoing Code and I will comply with
the Code in the future. I understand that any violation of the Code will subject me to appropriate disciplinary action, which may include
demotion or discharge.

Dated:

Name:

Title: